> sounds to me like criticism of the government

The article is not a long read [1]. It describes how current policy is dismantling and destroying the research infrastructure for diabetes, infrastructure which has started or has already borne significant fruit. It encapsulates a criticism of the administration, and it’s definitely scathing, but it’s far from a partisan rant.

For example: “This CD3-directed monoclonal antibody has been approved by the U.S. Food and Drug Administration to prevent type 1 diabetes in people aged 8 years and older with stage 2 type 1 diabetes. As a result, we are a major step closer to a cure for type 1 diabetes. With the potential to prevent the disease, screening programs for type 1 diabetes are being initiated worldwide.

…

Two examples are the Human Islet Research Network (HIRN) and the Integrated Islet Distribution Program (IIDP). HIRN aims to advance our understanding of how β-cells are lost in human type 1 diabetes and to find inventive strategies to protect or replace β-cells in people with the disease.”

The funding for that research is being cut. If you have a loved one with or at risk of getting diabetes, this could be the difference between vastly different levels of quality of life and years of life versus death.

[1] https://diabetesjournals.org/care/article/49/6/901/164764/Mi...

▲

roenxi an hour ago | parent [-]

> The funding for that research is being cut. If you have a loved one with, or at risk of getting, diabetes, this could be the difference between vastly different levels of quality of life and years of life versus death.

So just to jump back to the "The article they were distributing is pretty clearly about diabetes" thing mere comments ago - this seems to be about budgets and administrative matters. Those are generic concerns. In fact, in my unhumble opinion, this looks a lot like the sort of document written by someone with poor marketing skills worried that their budget is going to get cut in the near future. Especially since the conference organisers didn't think there was special merit to it.

There isn't much (if any) research here. It can reasonably be said to be out of scope for a diabetes conference if the organisers don't want to include it. All of us would like a larger budget, we don't need to listen to other people present on the topic of how they also want larger budgets. That is a political topic.

▲

JumpCrisscross an hour ago | parent | next [-]

> It can reasonably be said to be out of scope for a diabetes conference if the organisers don't want to include it

I’d agree with you if this happened at the journal level. It didn’t. The journal published it. Like, an astronomical conference paper describing why a new telescope design is a waste of money isn’t basic research, but it’s absolutely topical. (It could also reasonably be branded as political.)

The article is about the research infrastructure supporting diabetes research. If diabetes researchers aren’t allowed to comment on whether diabetes funding is working or wasteful in their own journals, or present their published journal findings at their own conferences, you’re not going to get any basic diabetes research.

> we don't need to listen to other people present on the topic of how they also want larger budgets. That is a political topic

It is. It’s also about diabetes. Debating which research avenues are more promising than others is absolutely political. It’s also at the heart of science. And frankly, informing fellow researchers and policymakers of the boring parts of the science is part of a scientist’s job.

Also, importantly, they aren’t asking for more budget in the article. They’re pointing out that the appropriated funds aren’t being delivered. They’re being literally misappropriated by OMB and HHS.

▲

roenxi an hour ago | parent [-]

I mean, so the concern here is what - HN disagrees with a decision made by an ADA organiser at a conference related to whether budgets and administration is appropriate in conference scope?

They got to have their say. Editorial published, made international news. I imagine all the conference attendees read it if they cared. Seems like a non-issue. Can we find a real problem for me to read up on instead? I'm having fun I suppose but I'm not seeing why we need to be all up in their business.

I bet less than 10% of the HN people who read the article even get to the "Misguided Brushes of a Pen..." editorial to find out what their complaint is.

	▲	JumpCrisscross 28 minutes ago \| parent [-]
		> the concern here is what ADA is violating its own code of conduct to suppress an article that calls out potentially-illegal misappropriation of diabetes-research funding by OMB and HHS, funding which falls in a results-oriented tradition and/or cuts off strong candidates for future therapies. > Seems like a non-issue Half of the front page usually is. You’re engaging with this content, so there is clearly something going on. Personally, I flagged excerpts of the article to one of my Senator’s staffers. They weren’t aware of it, and will be surfacing the article to their boss, a doctor, tomorrow. If HHS is fucking around with Congressional appropriations on a healthcare issue germane to our state, they probably shouldn’t have gone out of their way to draw attention to it during an appropriation cycle.

▲

tremon 32 minutes ago | parent | prev [-]

It can reasonably be said to be out of scope for a diabetes conference if the organisers don't want to include it

So the organisers of a conference can control the topics that its attendees want to talk about in the hallways of the venue? They don't have to extend any agency to the attendees, they're just dumb consumers here?